Zentalis Pharmaceuticals Inc To Host Investor Call Transcript
Welcome to the Zentalis Pharmaceuticals' Azenosertib Clinical Update Call. (Operator Instructions) As a reminder, this event is being recorded.
I will now hand the call over to Adam Levy, Senior Vice President, Investor Relations at Zentalis. Thank you. You may begin.
Good morning. Thank you for joining us today for our Azenosertib Clinical Update Call.
Before we begin, I'd like to take care of a few housekeeping items. I invite you to visit the Investors section of our website to view the webcast slides, today's press release on our azenosertib monotherapy dose optimization data and our May 25 press release on our azenosertib plus chemotherapy combination data, which was also presented yesterday at ASCO as Abstract 5513.
During today's presentation, we will be making forward-looking statements. Each forward-looking statement is subject to risks and uncertainties that could cause actual results to differ materially from those described in these statements. Additional information
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
